Figure S8 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601691

2024-01-01

Abstract:The less accessible loci found in cluster 3.

What problem does this paper attempt to address?

Figure S3 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601718

2024-01-01

Abstract:Single-cell RNA sequencing analysis the expression of CD27 and CD11b in NK cell clusters from DR-fed mice.
Figure S1 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601727

2024-01-01

Abstract:Gene Ontology (GO) enrichment analysis on differential marker expression patterns in clusters of NK cells under dietary restriction (DR) compared to control.
Figure S2 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601721

2024-01-01

Abstract:Trajectory analysis NK cell development from normal diet or DR-fed mice.
Figure S7 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601694

2024-01-01

Abstract:DR-fed mice promote the accumulation of DP NK cells by enhancing the expression of Eomes and its downstream target CXCR3.
Figure S6 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601700

2024-01-01

Abstract:T-bet deficiency does not impact NK cell activation.
Figure S5 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601703

2024-01-01

Abstract:DR treatment enriches the Eomes expression and functional DP NK cells by suppressing mTORC1 signaling.
Figure S4 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.27601709

2024-01-01

Abstract:DR-fed mice maintained their ability to suppress the growth of lung melanoma tumor cells, despite CD8 T cell depletion.
A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin.

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.cir-23-0944

IF: 10.1

2024-01-01

Cancer Immunology Research

Abstract:Abnormal metabolism in tumor cells represents a potential target for tumor therapy. In this regard, dietary restriction (DR) or its combination with anticancer drugs is of interest as it can impede the growth of tumor cells. In addition to its effects on tumor cells, DR also plays an extrinsic role in restricting tumor growth by regulating immune cells. NK cells are innate immune cells involved in tumor immunosurveillance. However, it remains uncertain whether DR can assist NK cells in controlling tumor growth. In this study, we demonstrate that DR effectively inhibits metastasis of melanoma cells to the lung. Consistent with this, the regression of tumors induced by DR was minimal in mice lacking NK cells. Single-cell RNA sequencing analysis revealed that DR enriched a rejuvenated subset of CD27+CD11b+ NK cells. Mechanistically, DR activated a regulatory network involving the transcription factor Eomesodermin (Eomes), which is essential for NK-cell development. First, DR promoted the expression of Eomes by optimizing mTORC1 signaling. The upregulation of Eomes revived the subset of functional CD27+CD11b+ NK cells by counteracting the expression of T-bet and downstream Zeb2. Moreover, DR enhanced the function and chemotaxis of NK cells by increasing the accessibility of Eomes to chromatin, leading to elevated expression of adhesion molecules and chemokines. Consequently, we conclude that DR therapy enhances tumor immunity through nontumor autonomous mechanisms, including promoting NK-cell tumor immunosurveillance and activation.
A single-cell analysis of the NK-cell landscape reveals that dietary restriction boosts NK cell antitumor immunity via Eomesdermin

Junming He,Donglin Chen,Wei Xiong,Yuande Wang,Shasha Chen,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1158/2326-6066.cir-23-0944

IF: 10.1

2024-08-18

Cancer Immunology Research

Abstract:Abnormal metabolism in tumor cells represents a potential target for tumor therapy. In this regard, dietary restriction (DR) or its combination with anticancer drugs is of interest as it can impede the growth of tumor cells. In addition to its effects on tumor cell, DR also plays an extrinsic role in restricting tumor growth by regulating immune cells. Natural killer (NK) cells are innate immune cells involved in tumor immunosurveillance. However, it remains uncertain whether DR can assist NK cells in controlling tumor growth. Herein, we demonstrate that DR effectively inhibits metastasis of melanoma cells to the lung. Consistent with this, the regression of tumors induced by DR was minimal in mice lacking NK cells. Single-cell RNA sequencing analysis revealed that DR enriched a rejuvenated subset of CD27+CD11b+ NK cells. Mechanistically, DR activated a regulatory network involving the transcription factor Eomesodermin (Eomes), which is essential for NK-cell development. Firstly, DR promoted the expression of Eomes by optimizing mTORC1 signaling. The upregulation of Eomes revived the subset of functional CD27+CD11b+ NK cells by counteracting the expression of T-bet and downstream Zeb2. Moreover, DR enhanced the function and chemotaxis of NK cells by increasing the accessibility of Eomes to chromatin, leading to elevated expression of adhesion molecules and chemokines. Consequently, we conclude that DR therapy enhances tumor immunity through non-tumor autonomous mechanisms, including promoting NK-cell tumor immunosurveillance and activation.

oncology,immunology
Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia A. Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Li Shen,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22494754

2023-01-01

Abstract:IL-6 modulates expression of NK receptor and their ligands in EGFR mutant tumors.
Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia A. Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Li Shen,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22494757.v1

2023-01-01

Abstract:EGFR-mutant NSCLC EGFR-independent tumor model is refractory to EGFR-TKI treatment.
Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Ли Шен,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael A. Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22490453.v1

2023-01-01

Abstract:EGFR-mutant NSCLC tumor cells with acquired resistance to an EGFR-TKI display augmented IL-6 gene expression.
Supplementary Table 3 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Inna Smalley,Zhihua Chen,Manali S. Phadke,Jiannong Li,Xiaoqing Yu,Clayton Wyatt,Brittany Evernden,Jane L. Messina,Amod A. Sarnaik,Vernon K. Sondak,Chaomei Zhang,Vincent Law,Nam Tran,Arnold Etame,Robert J.B. Macaulay,Zeynep Eroglu,Peter Forsyth,Paulo C. Rodríguez,Y. Ann Chen,Keiran S.M. Smalley

DOI: https://doi.org/10.1158/1078-0432.22481001

2023-01-01

Abstract:Supplemental Table 3: top genes that differentiate each cluster of T/NK cells
Eomesodermin spatiotemporally orchestrates the early and late stages of NK cell development by targeting KLF2 and T-bet, respectively

Junming He,Donglin Chen,Wei Xiong,Xinlei Hou,Yuhe Quan,Meixiang Yang,Zhongjun Dong

DOI: https://doi.org/10.1038/s41423-024-01164-8

2024-05-15

Cellular and Molecular Immunology

Abstract:Eomesodermin (Eomes) is a critical factor in the development of natural killer (NK) cells, but its precise role in temporal and spatial coordination during this process remains unclear. Our study revealed that Eomes plays distinct roles during the early and late stages of NK cell development. Specifically, the early deletion of Eomes via the CD122-Cre transgene resulted in significant blockade at the progenitor stage due to the downregulation of KLF2, another important transcription factor. ChIP-seq revealed direct binding of Eomes to the conserved noncoding sequence (CNS) of Klf2 . Utilizing the CHimeric IMmune Editing (CHIME) technique, we found that deletion of the CNS region of Klf2 via CRISPRi led to a reduction in the NK cell population and developmental arrest. Moreover, constitutive activation of this specific CNS region through CRISPRa significantly reversed the severe defects in NK cell development caused by Eomes deficiency. Conversely, Ncr1-Cre- mediated terminal deletion of Eomes expedited the transition of NK cell subsets from the CD27 + CD11b + phenotype to the CD27 − CD11b + phenotype. Late-stage deficiency of Eomes led to a significant increase in T-bet expression, which subsequently increased the expression of the transcription factor Zeb2. Genetic deletion of one allele of Tbx21 , encoding T-bet, effectively reversed the aberrant differentiation of Eomes-deficient NK cells. In summary, we utilized two innovative genetic models to elucidate the intricate mechanisms underlying Eomes-mediated NK cell commitment and differentiation.

immunology
T-BET and EOMES sustain mature human NK cell identity and antitumor function

Pamela Wong,Jennifer A Foltz,Lily Chang,Carly C Neal,Tony Yao,Celia C Cubitt,Jennifer Tran,Samantha Kersting-Schadek,Sathvik Palakurty,Natalia Jaeger,David A Russler-Germain,Nancy D Marin,Margery Gang,Julia A Wagner,Alice Y Zhou,Miriam T Jacobs,Mark Foster,Timothy Schappe,Lynne Marsala,Ethan McClain,Patrick Pence,Michelle Becker-Hapak,Bryan Fisk,Allegra A Petti,Obi L Griffith,Malachi Griffith,Melissa M Berrien-Elliott,Todd A Fehniger

DOI: https://doi.org/10.1172/JCI162530

2023-07-03

Abstract:Since the T-box transcription factors (TFs) T-BET and EOMES are necessary for initiation of NK cell development, their ongoing requirement for mature NK cell homeostasis, function, and molecular programming remains unclear. To address this, T-BET and EOMES were deleted in unexpanded primary human NK cells using CRISPR/Cas9. Deleting these TFs compromised in vivo antitumor response of human NK cells. Mechanistically, T-BET and EOMES were required for normal NK cell proliferation and persistence in vivo. NK cells lacking T-BET and EOMES also exhibited defective responses to cytokine stimulation. Single-cell RNA-Seq revealed a specific T-box transcriptional program in human NK cells, which was rapidly lost following T-BET and EOMES deletion. Further, T-BET- and EOMES-deleted CD56bright NK cells acquired an innate lymphoid cell precursor-like (ILCP-like) profile with increased expression of the ILC-3-associated TFs RORC and AHR, revealing a role for T-box TFs in maintaining mature NK cell phenotypes and an unexpected role of suppressing alternative ILC lineages. Our study reveals the critical importance of sustained EOMES and T-BET expression to orchestrate mature NK cell function and identity.
Supplementary Figure S8 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142117

2024-01-01

Abstract:Supplementary Figure S8. Bulk RNA-sequencing of tumor myeloid cells 7 days after RT and αEGFR-IFNα
Figure S3 from Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC

Haoyu Sun,Jing Xu,Qiang Huang,Mei Huang,Kun Li,Kun Qu,Hao Wen,Renyong Lin,Meijuan Zheng,Haiming Wei,Weihua Xiao,Rui Sun,Zhigang Tian,Cheng Sun

DOI: https://doi.org/10.1158/0008-5472.22418910

2023-01-01

Abstract:Figure S3 shows (A) Cumulative percentage of IFN-γ on sorted CD160- or CD160+ NK cells of peripheral blood; (B) Scatterplot of global gene expression profiles of CD160+ and CD160- NK subsets; (C) Distribution by functional category of up- or down-regulated genes in CD160+ NK cells compared to CD160- NK cells; (D) Overview of functional pathway analysis; (E) Chemokine- or (F) cytokine- related profiles of CD160+ and CD160- NK cells; and (G) GSEA of genes up-regulated in CD160+ NK cells overlapping with gene sets from IL-2-stimulated NK cells, IL-15-stimulated NK cells and CD57- NK cells.
Supplementary Figure S4 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142132

2024-01-01

Abstract:Supplementary Figure S4. Human expression of FOXP3 with RT and correlation with a Human DC_Ccl22 Homolog Score among TCGA cohorts
Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142111

2024-01-01

Abstract:Supplementary Figure S9. Changes in gene expression associated with ISG + cDC2 among sequencing results
Single-cell transcriptomics reveals comprehensive microenvironment and highlights the dysfuntional state of NK cells in endometrioid carcinoma

Wenjie Shi,Wuchen Wu,Jing Wang,Xianghong Meng

DOI: https://doi.org/10.1097/md.0000000000037555

IF: 1.6

2024-03-30

Medicine

Abstract:Endometrioid endometrial cancer (EEC) is one of the most common gynecologic malignancies. The interaction between cancer cells and the cells in the tumor microenvironment (TME) plays a crucial role in determining disease progression and response to treatment. To better understand the diversity in the TME of ECC, we conducted a comprehensive analysis using single-cell RNA sequencing across 21 samples, including 16 ECC and 5 adjacent normal tissues. We primarily focused on tumor-infiltrating natural killer (NK) cells and their cell–cell interactions with other immune cell types. We identified a CD56dim_DNAJB1 NK cells subset, which had low cytotoxic capability and high stress levels, suggesting a dysfunctional state. This subset showed strong interactions with tumor-associated macrophages through several ligand–receptor pairs. Additionally, we observed that tumor-infiltrating LAMP3+ dendritic cells may inhibit CD8+ T cells or attract regulatory T cells to the tumor area. These dendritic cells also had impaired activation effects on NK cells within the TME. Our study provides valuable insights into the role of NK cells in cancer immunity and highlights the potential of targeting specific NK cell subsets for therapeutic purposes.

medicine, general & internal

Figure S8 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S3 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S1 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S2 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S7 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S6 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S5 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

Figure S4 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin

A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity Via Eomesodermin.

A single-cell analysis of the NK-cell landscape reveals that dietary restriction boosts NK cell antitumor immunity via Eomesdermin

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Supplementary Table 3 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Eomesodermin spatiotemporally orchestrates the early and late stages of NK cell development by targeting KLF2 and T-bet, respectively

T-BET and EOMES sustain mature human NK cell identity and antitumor function

Supplementary Figure S8 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Figure S3 from Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC

Supplementary Figure S4 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Single-cell transcriptomics reveals comprehensive microenvironment and highlights the dysfuntional state of NK cells in endometrioid carcinoma